![ECOG-ACRIN logo[19516]275×75](https://blog-ecog-acrin.org/wp-content/uploads/2021/03/ECOG-ACRIN-logo19516275x75.png)
May 1, 2024
A new trial in sarcoma; MSI testing for gastroesophageal cancer; Spring Group Meeting and ASCO highlights
April 9, 2024
A new trial in glioblastoma; leadership transitions; upcoming Group Meeting highlights
March 7, 2024
Big data projects near activation; APP Working Group builds momentum; ECOG-ACRIN welcomes Winn CILA scholar
February 9, 2024
The co-chairs commemorate the late Dr. Edith Mitchell, welcome the new NCI Director, and reflect on the DREAMseq melanoma trial results
February 9, 2024
In January, the medical community lost an acclaimed oncology physician, researcher, teacher, and health equity pioneer
February 9, 2024
Amidst a persistent drug shortage, the BRIDGE trial seeks another possible first-line treatment option for patients
February 9, 2024
A member of ECOG-ACRIN since 2014
February 9, 2024
Summaries and links to timely information about research results in medical journals, recognition of research leaders, and more
December 19, 2023
The co-chairs reflect on the year's key accomplishments and look ahead to 2024
December 19, 2023
In November, the cancer research community lost a trailblazer in cancer research and community oncology who was a national champion for diversity
December 16, 2023
Summaries and links to timely information about research results in medical journals, recognition of research leaders, and more
October 19, 2023
Advanced Practice Providers Working Group debuts soon; community-focused column highlights genetic testing challenges; real-world data efforts accelerate